DaVita Inc. (NYSE: DVA) to report earnings after the bell. Last quarter, revenue met expectations at $3.42 billion, up 4.8% YoY, but EPS missed analyst estimates. This quarter, revenue expected to grow 6.4% YoY to $3.51 billion, with adjusted earnings at $3.19 per share. Analysts reconfirm estimates, business expected to stay the course. Peers in healthcare providers & services segment reported mixed results – HCA Healthcare up 6.7%, UnitedHealth up 12.3%. DaVita down 4.3% heading into earnings with analyst price target of $143. Read our full analysis on DaVita and peers’ results.

Read more at Barchart: DaVita (DVA) Q4 Earnings: What To Expect